resources allocated for the process for the advisory review of prescription drug advertising
(9)The term “resources allocated for the process for the advisory review of prescription drug advertising” means the expenses incurred in connection with the process for the advisory review of prescription drug advertising for— (A)officers and employees of the Food and Drug Administration, contractors of the Food and Drug Administration, advisory committees, and costs related to such officers, employees, and committees, and to contracts with such contractors; (B)management of information, and the acquisition, maintenance, and repair of computer resources; (C)leasing, maintenance, renovation, and repair of facilities and acquisition, maintenance, and repair of fixtures, furniture, scientific equipment, and other necessary materials and supplies; (D)collection of fees under this section and accounting for resources allocated for the advisory review of prescription drug advertising; and (E)terminating the program under this section pursuant to subsection (f)(2) if that becomes necessary.